Important changes coming 22 October 2018
Version 3 of the Criteria is coming!
The Ig Governance Program is pleased to announce that Version 3 of the Criteria is planned for release on 22 October 2018. The team is continuing to focus efforts on entering the new Criteria into BloodSTAR, ready for implementation.
What are the key things you need to know now?
- The new Criteria will be released in an online format only in BloodSTAR
- Some authorisations will be moved automatically, more information may be requested for others at the next review
- Indications will be more descriptive to help you select the appropriate one for your patient
- The qualifying criteria will be more definitive for some conditions and additional evidence will be required, so it may take a little more time to complete the additional information required
- In a small number of cases, funding of Ig therapy for certain medical conditions identified by clinical specialist groups will not continue, and more detail will be provided soon to help you to manage this with your patients
- There will be better guidance for patient eligibility and requirements to trial Ig therapy
- Formal review will always be needed to continue receiving Ig funded under the national blood arrangements
- Reporting of review outcomes is now enabled for all conditions
- Dosing will be more definitive
- BloodSTAR will be easier to use
The transition to Version 3 of the Criteria will include clear communication to doctors, nurses, patients and dispensers of Ig nationally. Starting in the next few weeks, the NBA will be communicating key messages and detailed information via email, system messaging, promotional material/flyers, companion guides, newsletters and in person at conferences and information sessions. Communication material will also be available for download from the NBA website.
For more information visit the new Criteria Version 3 page coming over the next few weeks.
BloodSTAR implementation in NSW
The implementation of BloodSTAR in NSW is now scheduled to occur in conjunction with the Version 3 Criteria on 22 October 2018. If you are in NSW and are involved in the prescription, use or management of immunoglobulin, you will soon be hearing how this will affect you and what you may need to do to get ready. The NBA is working closely with the NSW Ministry of Health and the Blood Service to make sure the transition to BloodSTAR is as smooth as possible.
BloodSTAR update released 1 July 2018
There are currently over 8,000 patients in BloodSTAR with active authorisations and approximately 8,500 registered users as Authorisers, Medical Officers, Nurses or Facility Administrators. The system continues to have high use with 627 initial authorisation requests and 10,431 dispense episodes of Ig in BloodSTAR nationally during June 2018.
The NBA continues to work to improve its blood sector systems to ensure they meet the requirements of end users efficiently and effectively. There is a new update of BloodSTAR which is targeted for release on Sunday 1 July 2018.
This update will include new functions and enhancements that will improve the usability and functionality of the system. Upcoming enhancements include:
- ability to extract treating medical specialists that are linked to active authorisations that may not have a BloodSTAR account
- display of additional information typed into the criteria manager for qualifying criteria during an authorisation request
- new sound-alike and keyword functioning for Medical Condition/Specific Condition/Indication search function when creating requests
- ability for prescriber to see relevant criteria above the evidence item on the electronic form
- improved search capabilities to improve results when searching for patients or medical conditions
- help menu including a frequently asked questions page
- news display on homepage
- link to support material and a Contacts page
For more information on BloodSTAR visit www.blood.gov.au/bloodstar.
Did you know?
Reminder to Medical Officers
Registering your specialty with AHPRA
Medical specialists must have their speciality registered with the Australian Health Practitioner Regulation Agency (AHPRA) for the Ig Governance Program to recognise the specialist qualification. BloodSTAR is linked to the AHPRA database, therefore if a clinician does not register all applicable specialist qualifications with AHPRA BloodSTAR will not be able to recognise that particular speciality for the clinician. Visit http://www.ahpra.gov.au/registration.aspx to check your registration details.
Keep up to date
Keep up to date with the latest Immunoglobulin Governance updates - create a BloodPortal account and from the home page click on ‘My Subscriptions’ and ‘Subscribe’ to Immunoglobulin. The latest update is available at Ig Governance Criteria and Progress Updates.